Skip to main content

Institutional Biosafety Committee-Human Subjects Roster

Current IBC-HS Roster

Print Committee Roster: Institutional Biosafety Committee-Human Subjects

Vanderbilt Human Research Protection Program
Institutional Biosafety Committee-Human Subjects
NIH Registration Number TN00040

The IBC-HS Committee meets the first and third Tuesday of the month from 8:30 to 10:30 am. Meeting locations are subject to change. Please call the VHRPP office to confirm meeting location (322-2918).

Effective – September 1, 2017

Antonis Hatzopoulos, PhD – Chair Cell and Developmental Biology
Allison Wheeler, MD – Vice-Chair Transfusion Medicine
David Chism, MD Oncology/Cell and Molecular Biology
Carrie Kitko, MD Pediatric Stem Cell Transplantation Program
Douglas Johnson, MD, MSCI Hematology/Oncology
Lori Rolando, MD, MPH Occupational Health and Safety
Robin Trundy, MS Assistant Director, VEHS/Biological Safety Officer
Rick Malone, PharmD, MS Investigational Drug Service
Brenton Harrison, BBA Community Member
Eric Sacharczyk, BS Community Member


Ray Stokes Peebles, PhD Infectious Diseases
Justin M. Balko, PharmD, PhD Hematology/Oncology
Jennifer Bounds Community Member


Vanderbilt’s Institutional Biosafety Committee-Human Subjects (IBC-HS) is authorized by the National Institutes of Health (NIH) to approve research projects involving the use of recombinant DNA and synthetic nucleotide research involving humans. Use the IBC application that is embedded in the IRB application and guidelines to submit proposals to the IBC-HS. If you need help in completing and IBC-HS application, contact the IRB to have the a member of the IBC-HS team to assist you.